{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:02:46Z","timestamp":1789038166301,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.anndiagpath.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T20:31:38Z","timestamp":1463603498000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1"],"prefix":"10.1016","volume":"23","author":[{"given":"Abbas","family":"Agaimy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Hadravsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0005","first-page":"562","article-title":"A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases","volume":"122","author":"Monda","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00000478-199608000-00003","article-title":"Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity","volume":"20","author":"Perez-Ordonez","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0015","first-page":"1577","article-title":"CNA.42, a new monoclonal antibody directed against a fixative-resistant antigen of follicular dendritic reticulum cells","volume":"151","author":"Raymond","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<294::AID-CNCR13>3.0.CO;2-W","article-title":"Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized","volume":"79","author":"Chan","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajh.20852","article-title":"Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature","volume":"82","author":"Soriano","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0030","first-page":"144","article-title":"Follicular dendritic cell tumor: review of the entity","volume":"15","author":"Perez-Ordo\u00f1ez","year":"1998","journal-title":"Semin Diagn Pathol"},{"issue":"38 Suppl 1","key":"10.1016\/j.anndiagpath.2016.05.003_bb0035","doi-asserted-by":"crossref","first-page":"E2241","DOI":"10.1002\/hed.24115","article-title":"Follicular dendritic cell sarcoma of the head and neck: case report, literature review, and pooled analysis of 97 cases","author":"Pang","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000478-200106000-00003","article-title":"Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association","volume":"25","author":"Cheuk","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/PAS.0000000000000170","article-title":"Inflammatory pseudotumor\u2013like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions","volume":"38","author":"Li","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.humpath.2011.02.029","article-title":"Folliculocentric B-cell\u2013rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders","volume":"43","author":"Lorenzi","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00428-008-0603-z","article-title":"Sarcoma of follicular dendritic cells with features of sinus lining cells\u2014a new subtype of reticulum cell sarcoma?","volume":"452","author":"Krokowski","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0022-3859.147058","article-title":"Extranodal follicular dendritic cell sarcoma: a frequently misdiagnosed entity","volume":"61","author":"Pai","year":"2015","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.3800294","article-title":"A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor","volume":"18","author":"Grogg","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/7P8U659JBJCV6EEU","article-title":"Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors","volume":"128","author":"Yu","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0075","first-page":"165","article-title":"Spindle cell tumor of lymph node of probable reticulum origin associated with multiclonal gammopathy","volume":"140","author":"Michal","year":"1994","journal-title":"Zentralbl Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/modpathol.3800954","article-title":"Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy","volume":"20","author":"Volante","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/PAS.0000000000000590","article-title":"Expression of programmed cell death 1 ligands (PD-L1 and PD-L2) in histiocytic and dendritic cell disorders","volume":"40","author":"Xu","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/his.12366","article-title":"Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel","volume":"65","author":"Agaimy","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-015-1459-3","article-title":"Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen","volume":"130","author":"Menke","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0100","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","article-title":"Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)","volume":"44","author":"Houang","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.pai.0000213113.50849.9e","article-title":"Intra-abdominal follicular dendritic cell sarcoma with marked pleomorphic features and aberrant expression of neuroendocrine markers: report of a case with immunohistochemical analysis","volume":"15","author":"Padilla-Rodr\u00edguez","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0110","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.18632\/oncotarget.4378","article-title":"Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1","volume":"6","author":"Gatalica","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.anndiagpath.2016.05.003_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/modpathol.2015.130","article-title":"Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-\u03baB regulatory genes","volume":"29","author":"Griffin","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","article-title":"Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms","volume":"65","author":"Go","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0125","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/PAI.0000000000000238","article-title":"MDM2 expression in extranodal abdominal and retroperitoneal follicular dendritic cell sarcomas, mimicking dedifferentiated liposarcomas","volume":"24","author":"Creytens","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000478-200205000-00013","article-title":"Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis","volume":"26","author":"Cokelaere","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000478-199405000-00013","article-title":"Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease","volume":"18","author":"Chan","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.dad.0000171606.55810.86","article-title":"Sarcoma arising in hyaline-vascular Castleman disease of skin and subcutis","volume":"27","author":"Kazakov","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0145","first-page":"37","article-title":"Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations","volume":"151","author":"Tallini","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.05.003_bb0150","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/ijc.23380","article-title":"HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon","volume":"122","author":"Italiano","year":"2008","journal-title":"Int J Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416301113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416301113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T19:52:35Z","timestamp":1536695555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416301113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":30,"alternative-id":["S1092913416301113"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.05.003","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}